Professional Documents
Culture Documents
Pathophysiology of Osteoarthritis
Pathophysiology of Osteoarthritis
Nurul Paramita Department of Physiology, Faculty of Medicine, Universitas Indonesia Jakarta, September 2013
What is Osteoarthritis ?
Formerly referred to as osteoarthrosis and degenerative joint disease
The most common form of arthritis Prior to 1986: no standard definition of OA existed; most discribed OA as a disorder of unknown etiology that
primarily affects the articular cartilage and subchondral bone in contrast to rheumatoid arthritis, a disorder that primarily affects the synovial membrane
1986, the Subcommittee on Osteoarthritis of the American College of Rheumatology Diagnostic and
Therapeutic Criteria Committee : A heterogeneous group of conditions that lead to joint symptoms and signs which are associated with the defective integrity of articular cartilage, in addition to related changes in the underlying bone at the joint margins
Kenneth D. Brandt, Michael Doherty, L. Stefan Lohmander, editors. In: Osteoarthritis, 2nd ed. Oxford University Press, 2003.
Kenneth D. Brandt, Michael Doherty, L. Stefan Lohmander, editors. In: Osteoarthritis, 2nd ed. Oxford University Press, 2003.
What is Osteoarthritis ?
A group of overlapping distinct diseases, which may have different etiologies but with similar biologic,
Not only affect the articular cartilage, but involve the entire joint, including the subchondral bone, ligaments,
Defined as a focal lesion of the articular cartilage, combined with a hypertrophic reaction (sclerosis) in the
subchondral bone and new bone formation (osteophytes) at the joint margins cartilage
Leads to fibrillation, fissures, gross ulceration and finally disappearance of the full thickness of articular Most common musculoskeleteal disorder worldwide
Pathophysiology OA
Not a degenerative disease
A dynamic process A potential repair process in response to joint insult and cartilage destruction
A variety of insults may trigger the need to repair. Once the process is
initiated, all the tissues in the joint are involved in what may be considered an adaptive response
The overall picture of OA resembles a failure in attempt at repair
Kenneth D. Brandt, Michael Doherty, L. Stefan Lohmander, editors. In: Osteoarthritis, 2nd ed. Oxford University Press, 2003.
Pathophysiology OA
The initiating process : originates in the bone or in the cartilage? The heterogeneous character of the OA further complicates this discussion It is accepted that OA may occur as a consequence of multiple causes:
blunt joint trauma biomechanical overloading inborn or acquired joint incongruency genetic defects in matrix components or assembly
Kenneth D. Brandt, Michael Doherty, L. Stefan Lohmander, editors. In: Osteoarthritis, 2nd ed. Oxford University Press, 2003.
H. Weinans , M. Siebelt , R. Agricola, S.M. Botter, T.M. Piscaer, J.H. Waarsing, Bone 51 (2012) 190196
Rat knee joint showing the cartilage and subchondral bone of a normal (healthy) control (A) and of a rat that underwent a running protocol of 5 kilometers per week for a period of 6 weeks (B). A striking difference in GAG staining in cartilage and clear hypertrophy of chondrocytes in the deep cartilage zone
Siebelt M, et al. Quantifying osteoarthritic cartilage changes accurately using in vivo microCT arthrography in three etiologically distinct rat models. J Orthop Res 2011;29:178894
Risk Factors
Systemic Factors
Age
Gender Genetic &hereditary
Kenneth D. Brandt, Michael Doherty, L. Stefan Lohmander, editors. In: Osteoarthritis, 2nd ed. Oxford University Press, 2003.
Estrogen defficiency
Nutritional factors (vitamin C & vitamin D)
Local Factors
Intrinsic
Extrinsic
Obesity Muscle weakness Repeated use of joint (occupational & athletic activities)
Disease of mechanics
Inflammation
OA as a disease of mechanics
The hypothesis is that OA is caused by increased forces across a local area of a joint
either from
(1) abnormal anatomy (congenital or acquired) leading to increased focal stress
models is among the best examples that abnormal mechanics causes OA.
In humans there are many examples of major joint injuries or abnormally
shaped joints produce high levels of focal stress across the joint causing OA
Removal or injury to meniscus Tears of ACL
Pathophysiology of OA
Inflammation in OA is mostly a consequence of pathomechanics
Joint injury, abnormal shaped joint, and/or excess load with consequent pathomechanics Inflammatory Cytokine Release (cartilage, synovium, other)
Joint damage
Facts to remember:
Major risk factors for knee OA according to recent reviews include: older age,
structures within the knee to injury), all of the factors that have been identified, consistently represent types of mechanical overload
Inflammation theory
Many soluble mediators (cytokines or prostaglandins) can increase the
production of MMP by chondrocytes led to the first step of inflammation theory inflammatory mediators
Inflammation theory
Synovitis
(local inflammation) Innate immunity
Cartilage fragment fall into the joint and contact the synovium
Innate immunity
Innate immune system/non-spesific immune system: comprises the cells and
mechanism that defend the host from infection by other organisms in a non specific manner
Triggered by: binding of pathogen-associated molecular pattern (PAMPs) and danger-
2008)
systemic pathway
properties in OA
Metabolic syndrome (MetS) rather than obesity itself has the greatest impact on the
with the prevalence of knee OA, and carotid plaque with distal interphalangeal OA
Oxidized lipids are the most likely triggering factors for cytokine production
activated intracellular signals in joint cells by mechanoreceptors present at the surface of joint cells (ion channels, integrin)
These signals may eventually lead to the over-expression of inflammatory
Conclusion
OA is not a degenerative disease, but a dynamic disease from repetitive
insult-repair process
OA are the result of an interplay between causes According to mechanics theory, OA is primarily caused by mechanical
the symptoms and structural progression of OA; leading to ongoing researches to find a disease modifying OA drugs